Blood News and Research

RSS

Repeated exposure to low level blasts causes harmful effects in brain

Repeated exposure to low level blasts (LLB) can cause symptoms similar to sports concussion. Soldiers or law enforcement officers called "breachers" receive training in using low level blasts for forced entry.

17 Sep 2013

Study shows that changes in diet, lifestyle choices may result in longer telomeres

A small pilot study shows for the first time that changes in diet, exercise, stress management and social support may result in longer telomeres, the parts of chromosomes that affect aging.

17 Sep 2013

Patients who receive automated telephone calls are more likely to have controlled hypertension

Patients who received automated telephone calls inviting them to get their blood pressure checked at a walk-in clinic were more likely to have controlled hypertension than patients who did not receive calls, according to a Kaiser Permanente study published today in the Journal of Clinical Hypertension.

17 Sep 2013

Researchers identify new link between meal times and daily changes in immune system

A new link between meal times and daily changes in the immune system has been identified by UC San Francisco researchers, and has led them to question assumptions about the roles of specific immune cells in infection and allergy.

17 Sep 2013

Vanderbilt examines ability of drug abatacept to prevent type 1 diabetes

Vanderbilt's Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

17 Sep 2013

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

The U.S. Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.

17 Sep 2013

Study reveals olive leaf extract can inhibit lead-induced brain injury

In recent years, neurotoxicity from exposure to low levels of lead in the environment has become increasingly prevalent. Therefore, the discovery of herbs that have lead-eliminating properties without harmful side effects is essential for the management of lead poisoning.

17 Sep 2013

Researchers identify biomarker that can predict diabetes risk

Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.

17 Sep 2013

Researchers find that people affected by cold sores have mutation in gene

Why some people are troubled by cold sores while others are not has finally been explained by scientists. Cold sores affect around one in five people but, until now, no one has been sure why some are more prone to the virus that causes them.

17 Sep 2013

Arginine therapy may be safe treatment for patients with sickle cell disease

Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.

17 Sep 2013

Gene panel predicts low-risk prostate cancer fate

Researchers from the USA have identified a three-gene signature that can predict prostate cancer progression in low Gleason score tumors.

16 Sep 2013

Financial incentives only partial solution for hypertension control

Providing financial incentives to general practitioners goes some way toward improving hypertension control in their patients, shows research published in JAMA.

16 Sep 2013

Affimed Therapeutics, LLS partner to co-fund AFM13 phase 2 trial for treatment of Hodgkin Lymphoma

Affimed Therapeutics AG and The Leukemia & Lymphoma Society today announced a partnership to co-fund a phase 2 trial with the Recruit-TandAb AFM13, a novel tetravalent bispecific antibody directed against human CD30 and CD16A in Hodgkin Lymphoma patients for whom currently available treatments have failed.

16 Sep 2013

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

ISA Pharmaceuticals B.V., a clinical-stage biopharmaceutical company focusing on rationally designed, fully synthetic therapeutic vaccines against cancer and persistent viral infections, today announced the initiation of a Phase I/II clinical study of its lead candidate ISA101 in HIV-positive men suffering from anal intraepithelial neoplasia.

16 Sep 2013

New data demonstrates efficacy of GelrinC implant for treating articular cartilage in injured knees

Regentis Biomaterials announced today new clinical data demonstrating the efficacy and safety of its GelrinC implant for treating articular cartilage in injured knees. As presented at the International Cartilage Repair Society World Congress in Izmir, Turkey, the clinical results demonstrated sustained knee function improvement over 24 months after implantation and significant pain reduction.

16 Sep 2013

New neuroimaging and bioinformatics tools for predicting psychotic disorders

A new EU project, METSY, develops and applies neuroimaging and bioinformatics tools to study how lipid metabolism is connected to psychotic disorders and metabolic co-morbidities such as metabolic syndrome and diabetes.

16 Sep 2013

ChipCare’s handheld analyzer secures largest investments in Canada's healthcare sector

An innovative, handheld point-of-care analyzer, developed by ChipCare Corporation, has secured one of the largest ever angel investments in Canada's healthcare sector. Phase II financing has closed, with an investment of $2.05M to support ChipCare's continuing development and commercialization over the next three years.

16 Sep 2013

Climate change not likely to make malaria situation worse in West Africa, say researchers

As public-health officials continue to fight malaria in sub-Saharan Africa, researchers are trying to predict how climate change will impact the disease, which infected an estimated 219 million people in 2010 and is the fifth leading cause of death worldwide among children under age 5.

16 Sep 2013

Drug used in patients for cancer treatment has beneficial effects on diabetes

A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway - a series of interaction among proteins - involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.

16 Sep 2013

Novel DiaRem scoring system can predict diabetes remission after gastric bypass surgery

US Scientists have developed a simple scoring system (DiaRem), based on four readily available preoperative patient characteristics, that can predict which candidates for gastric bypass surgery are likely to achieve diabetes remission within 5 years.

13 Sep 2013

Blood News and Research

Repeated exposure to low level blasts causes harmful effects in brain

Study shows that changes in diet, lifestyle choices may result in longer telomeres

Patients who receive automated telephone calls are more likely to have controlled hypertension

Researchers identify new link between meal times and daily changes in immune system

Vanderbilt examines ability of drug abatacept to prevent type 1 diabetes

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

Study reveals olive leaf extract can inhibit lead-induced brain injury

Researchers identify biomarker that can predict diabetes risk

Researchers find that people affected by cold sores have mutation in gene

Arginine therapy may be safe treatment for patients with sickle cell disease

Gene panel predicts low-risk prostate cancer fate

Financial incentives only partial solution for hypertension control

Affimed Therapeutics, LLS partner to co-fund AFM13 phase 2 trial for treatment of Hodgkin Lymphoma

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

New data demonstrates efficacy of GelrinC implant for treating articular cartilage in injured knees

New neuroimaging and bioinformatics tools for predicting psychotic disorders

ChipCare’s handheld analyzer secures largest investments in Canada's healthcare sector

Climate change not likely to make malaria situation worse in West Africa, say researchers

Drug used in patients for cancer treatment has beneficial effects on diabetes

Novel DiaRem scoring system can predict diabetes remission after gastric bypass surgery

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News